Plasma pentraxin 3 is higher in early ovarian hyperstimulation syndrome than in uncomplicated in vitro fertilization cycle of high-risk women

被引：0
|
作者：
Kati Korhonen
Leila Unkila-Kallio
Henrik Alfthan
Esa Hämäläinen
Aila Tiitinen
Tomi Mikkola
Juha Tapanainen
Hanna Savolainen-Peltonen
机构：
[1] University of Helsinki and Helsinki University Hospital,Obstetrics and Gynecology
[2] HUSLAB,Clinical Chemistry
[3] Helsinki University Hospital,PEDEGO Research Unit, Medical Research Center, Obstetrics and Gynecology
[4] University of Helsinki and Helsinki University Hospital,undefined
[5] Folkhälsan Research Center,undefined
[6] Biomedicum Helsinki,undefined
[7] University of Oulu and Oulu University Hospital,undefined
来源：
Archives of Gynecology and Obstetrics | 2020年 / 301卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1569 / 1578
页数：9
相关论文
共 50 条
  • [1] Plasma pentraxin 3 is higher in early ovarian hyperstimulation syndrome than in uncomplicated in vitro fertilization cycle of high-risk women
    Korhonen, Kati
    Unkila-Kallio, Leila
    Alfthan, Henrik
    Hamalainen, Esa
    Tiitinen, Aila
    Mikkola, Tomi
    Tapanainen, Juha
    Savolainen-Peltonen, Hanna
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 301 (06) : 1569 - 1578
  • [2] Prediction of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization
    Kahnberg, Annika
    Enskog, Anders
    Brannstrom, Mats
    Lundin, Kersti
    Bergh, Christina
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2009, 88 (12) : 1373 - 1381
  • [3] Genetic predictors of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization
    Delbaere, Anne
    Smits, Guillaume
    Vassart, Gilbert
    Costagliola, Sabine
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (11): : 590 - 591
  • [4] Genetic predictors of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization
    Anne Delbaere
    Guillaume Smits
    Gilbert Vassart
    Sabine Costagliola
    Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 : 590 - 591
  • [5] Identification of the High-Risk Patient for Ovarian Hyperstimulation Syndrome
    Papanikolaou, Evangelos G.
    Humaidan, Peter
    Polyzos, Nikolaos P.
    Tarlatzis, Basil
    SEMINARS IN REPRODUCTIVE MEDICINE, 2010, 28 (06) : 458 - 462
  • [6] Correctly timed coasting reduces the risk of ovarian hyperstimulation syndrome and gives good cycle outcome in an in vitro fertilization program
    Grochowski, D
    Wolczynski, S
    Kuczynski, W
    Domitrz, J
    Szamatowicz, J
    Szamatowicz, M
    GYNECOLOGICAL ENDOCRINOLOGY, 2001, 15 (03) : 234 - 238
  • [7] Risk factors for ovarian hyperstimulation syndrome in Thai patients using gonadotropins for in vitro fertilization
    Aramwit, Pornanong
    Pruksananonda, Kamthorn
    Kasettratat, Narat
    Jammeechai, Karnphat
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (12) : 1148 - 1153
  • [8] DECREASED INCIDENCE OF SEVERE OVARIAN HYPERSTIMULATION SYNDROME IN HIGH-RISK IN-VITRO FERTILIZATION PATIENTS RECEIVING INTRAVENOUS ALBUMIN - A PROSPECTIVE-STUDY
    SHALEV, E
    GILADI, Y
    MATILSKY, M
    BENAMI, M
    HUMAN REPRODUCTION, 1995, 10 (06) : 1373 - 1376
  • [9] Effect of letrozole on moderate and severe early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial
    Mai, Qingyun
    Hu, Xiaokun
    Yang, Gang
    Luo, Yingyi
    Huang, Kejun
    Yuan, Yuan
    Zhou, Canquan
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 216 (01) : 42.e1 - 42.e10
  • [10] Impact of cryopreservation and subsequent embryo transfer on the outcome of in vitro fertilization in patients at high risk for ovarian hyperstimulation syndrome
    Wiener-Megnazi, Z
    Lahav-Baratz, S
    Rothschild, E
    Abramovici, H
    Dirnfeld, M
    FERTILITY AND STERILITY, 2002, 78 (01) : 201 - 203
12345